KPMA Promote to Compose Consortium to Develop New Medicine

Published: 2001-11-23 06:59:00

Updated: 2001-11-23 06:59:00

KPMA put premise that the corporation model which Korean Pharmaceutical Industry can continue its development is the one progresses fair transaction and the other one with development capability of research and decided to concentrate their capability to materialize the corporation model.

KPMA announced that facing BT era in 21st century Japanese pharmaceutical industry having ambition to ta...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.